Position in AXSM
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$1,135,138
-$129,461 QoQ
Shares Held
6,716
-3.0% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
21 quarters on record
Voting authority
Sole 13.177486599166171.ToString("F0")%
Shared 0.ToString("F0")%
None 86.82251340083383.ToString("F0")%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. AXSM ranks #8 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
This page
|
6,716 | $1,135,138 |
All Filings in AXSM
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,135,138 | 6,716 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $1,264,599 | 6,924 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $887,204 | 7,607 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $462,478 | 5,466 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $671,598 | 7,473 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $595,941 | 7,403 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $582,699 | 7,302 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $586,180 | 7,365 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $573,307 | 8,203 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $299,799 | 4,172 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $257,328 | 4,172 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $506,127 | 6,562 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $694,331 | 15,561 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $217,735 | 5,685 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $209,112 | 5,535 | Shares | Sole | 2022-02-15 | |
| 2021-06-30 | $371,030 | 5,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $324,715 | 5,735 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $462,342 | 5,675 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $364,301 | 5,113 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $216,643 | 2,633 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $300,385 | 5,106 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||